Novo Nordisk is facing a massive wave of generic competitors to its injectable formulations of GLP-1 agonist semaglutide, used to treat diabetes and obesity, as a key patent in India is due to expire ...
Kaicey Baylor joined WJZ as a reporter in October 2024. Before coming to Charm City, she spent the last three years as a morning reporter and multiskilled journalist at 13News Now in Norfolk, Virginia ...
Since 1970, the North American bird population has declined by more than 25%. There are many factors driving this. And several things bird lovers can do to reverse the trend. On Point news analyst ...